A significant driving force behind the growth of the FMD vaccine market is anticipated to be the high animal density and rising population of livestock animals. In 2017, the U.S. Department of Agriculture reported that India had over 300 million cattle, followed by Brazil and China. The United Nations Food and Agriculture Organization (UN-FAO) factsheet states that there were around one billion pigs in the globe in 2017. With 455 million pigs, China has the largest number of pigs. If their movement is not controlled, infected animals can spread the virus to other animals. The vaccination of animals against FMD reduces current hazards and promotes sustainable animal population increase worldwide, particularly in areas where FMD outbreaks are more likely to occur.
Global Foot And Mouth Disease Vaccine Market is estimated to be valued at US$ 2,396.3 million in 2022 and is expected to exhibit a CAGR of 9.4% during the forecast period (2022-2030).
Prominent Companies in the Foot And Mouth Disease Vaccine Industry:
Indian Immunologicals Ltd.
Indian Immunologicals was established by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making vaccines available to farmers at an affordable price. The company has headquarters situated in Telangana, India, it is operational in more than 50 countries.